Quotient Limited (QTNT) Return on Investment ROI from the third quarter of 2023 to third quarter of 2021 and for the year 2023, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket
 


Quotient Limited  (NASDAQ: QTNT)


Quotient Limited's ROI from its third quarter of 2023 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Quotient Limited's ROI in the third quarter of 2023?
Quotient Limited recorded a cumulative net loss of $-124 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -100.79%.

Within the Healthcare sector 977 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 0 to 4863.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2022)
III. Quarter
(Sep 30 2022)
II. Quarter
(Jun 30 2022)
I. Quarter
(Mar 31 2022)
IV. Quarter
(Dec 31 2021)
III. Quarter
Y / Y Investment Change TTM -51 % -33.12 % -20.76 % -8.5 % 29.36 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 90 96 146 161 237
Return On Investment (TTM) -100.79 % -97.2 % -71.65 % -59.87 % -55.79 %
QTNT's Overall Ranking # 4863 # 0 # 0 # 0 #
Seq. Investment Change TTM -23.09 % -16.15 % -8.71 % -16.77 % 4.97 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -124 -156 -137 -125 -140




Return On Investment QTNT's Ranking
Within: No.
Industry # 16
Sector # 978
Overall # 4863

Return On Investment Statistics
High Average Low
-45.25 %
-74.09 %
-112.41 %
(Sep 30 2020)   (Dec 31 2022)







Financial Statements
Quotient Limited's III. Quarter Investments $ 90 Millions QTNT's Balance sheet
Quotient Limited's III. Quarter Income $ -13 Millions Quarterly QTNT's Income Statement
QTNT's Income by Division See QTNT's Income by Division


QTNT Annual Return On Investment (Mar 31 2022)
2022
(Mar 31 2021)
2021
(Mar 31 2020)
2020
(Mar 31 2019)
2019
(Mar 31 2018)
2018
Total Investments in Millions 161 160 195 152 97
Y / Y Investment Growth 0.5 % -17.9 % 28.22 % 57.37 % 20.62 %
Net Income in Millions -125 -111 -103 -105 -82
Y / Y Net Income Growth - - - - -
Annual Return On Investment -77.64 % -69.24 % -52.62 % -69.19 % -85.07 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
In Vitro & In Vivo Diagnostic Substances Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
QTNT's Roi Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for QTNT's Competitors
Subscribers only: Roi for Quotient Limited's Suppliers
Subscribers only: Return On Investment for QTNT's Customers

Other Ratios
QTNT's Roa QTNT's Inventory Turnover Ratio QTNT's Growth Rates QTNT's Dividend Statistics
QTNT's Profitability Ratios QTNT's Asset Turnover Ratio QTNT's Dividend Growth
QTNT's Roe QTNT's Valuation Ratios QTNT's Financial Strength Ratios QTNT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI


Date modified: 2026-09-08T15:22:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.